Dechra Pharmaceuticals PLC (DECP.L)
DECP.L on London Stock Exchange
716.00GBp
1:08pm IST
716.00GBp
1:08pm IST
Price Change (% chg)
-7.00p (-0.97%)
-7.00p (-0.97%)
Prev Close
723.00p
723.00p
Open
715.50p
715.50p
Day's High
719.00p
719.00p
Day's Low
713.00p
713.00p
Volume
6,383
6,383
Avg. Vol
80,462
80,462
52-wk High
791.50p
791.50p
52-wk Low
464.50p
464.50p
About
Dechra Pharmaceuticals PLC (Dechra) is a holding company. The Company operates in four segments: Product Development, European Pharmaceuticals, US Pharmaceuticals and Services. European Pharmaceuticals markets and sells pharmaceuticals and specialist pet foods to the veterinary profession in Europe. It comprises Dechra... (more)
Overall
| Beta: | 0.18 |
| Market Cap (Mil.): | £629.85 |
| Shares Outstanding (Mil.): | 87.12 |
| Dividend: | 4.34 |
| Yield (%): | 1.78 |
Financials
| DECP.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 44.01 | 34.93 | 35.13 |
| EPS (TTM): | 0.16 | -- | -- |
| ROI: | 5.75 | 19.47 | 18.83 |
| ROE: | 10.62 | 20.22 | 19.68 |
Dechra says profit rises 54 pct, warns of weak services sales
Feb 26 - Animal health company Dechra Pharmaceuticals Plc said its first-half pretax profit grew 54 percent, but warned that its core services unit had weak sales in January caused by a significant decline in footfall at veterinary practices.
BRIEF-Dechra Pharmaceuticals profit rises
LONDON, Feb 26 - Dechra Pharmaceuticals PLC : * H1 underlying profit before taxation was up 46.9% to 21 million STG * H1 group revenue increased by 20.4% to 252.2 million STG * Poor sales in January at services unit on bad weather caused significant
BRIEF-Dechra Pharma says first half in line
LONDON, Jan 8 - Dechra Pharmaceuticals PLC : * Trading across the group in the first half has been in line with management
BRIEF-Dechra makes $15 mln contingent payment
LONDON, Nov 30 - Dechra Pharmaceuticals PLC : * Payment in the sum of $15 million (£9.4 million) has been paid to the

Estimates